|
||
Home -> Products & Services -> Plasmid Platform -> SURETM TF Reporter Plasmids -> pAP1/RE-Reporter Plasmid | ||
Quick Inquiry |
pAP1/RE-Reporter Plasmid Item No.: PSP005Shipping: Plasmids on filter paper, or liquid plasmids, or lyophilized plasmids Storage: As indicated in the product datasheet or product label; according to the delivered product form, for plasmids on filter paper, store at 4°C, for liquid or lyophilized plasmids, store at less than -20°C. INTRODUCTION Activator protein 1 (AP-1) is a transcription factor composed of proteins belonging to the c-Fos, c-Jun, ATF and JDP families. AP1 transcription factor controls genes involved in cellular processes such as differentiation, proliferation, and apoptosis. The binding site of AP1 was identified as the 12-O-Tetradecanoylphorbol-13-acetate (TPA) response element (TRE) with the consensus sequence 5’-TGA G/C TCA-3’. RGBiotech offers multiple types of pAP1/RE-Reporter plasmids that contains multiple tandem repeats of AP1 binding sites upstream of a reporter gene driven by a basal / minimal promoter. Our pAP1/RE-Reporter plasmids can be used in monitoring AP1 activities, screening of AP1 activitors / inhibitors / homologs, studying regulatory mechanism of AP1 gene expression, by simply detecting reporter gene expression after delivery of the plasmid into target cells. VECTOR INFORMATION -> Vector backbone options: non-viral mammalian expression plasmid, lentiviral expression plasmid, adenoviral expression plasmid, AAV expression plasmid-> Reporter gene options: GFP, RFP, Luciferase, SEAP, CAT -> Mammalian antibiotic selection options: none, puromycin, neomycin, hygromycin Custom construction of pAP1/RE-Reporter Plasmid is also available at RGBiotech. Welcome to contact us at admin@rgbiotech.com for a quotation. |
|
Products & Services Resources | ||
Home Products & Services Support About Us Contact Us |
Promotions Flyers Brochures Publications News & Events |
Terms & Conditions Privacy Disclaimers |
Contact Us EMAIL: admin@rgbiotech.com |
||
© RGBiotech All Rights Reserved. | |||||